Supreme Industries' Q2FY24 Financial Performance Review

In this financial performance review, we delve into the results of Supreme Industries for Q2FY24 and analyze key metrics, including revenue, expenses, net profit, and margin.

 

ParticularsQ2FY23YoY (% change)Q1FY24QoQ (% change)Q2FY24
Total Income (₹crs.)2,09210.952,382-2.562,321
Expenses (₹crs.)2,00512,120-4.482,025
Net Profit (₹crs.)82196.3421513.02243
Margin (%)3.926.559.031.4410.47

 

REVENUE: 
Supreme Industries reported a total income of ₹2,321 crores for Q2FY24. This represents a marginal decrease of -2.56% sequentially. On a year-on-year basis, the company achieved a healthy 10.95% growth in total income compared to Q2FY23.

 

EXPENSES: 
Expenses in Q2FY24 amounted to ₹2,025 crores, reflecting a -4.48% reduction compared to the preceding quarter. The company displayed a prudent approach to cost management. On a year-on-year basis, expenses increased slightly by 1%, indicating effective cost control measures.

 

NET PROFIT: 
The net profit of the company for Q2FY24 was ₹243 crores, showing a 13.02% increase compared to Q1FY24. On a year-on-year basis, the company experienced a substantial growth of 196.34%, highlighting its strong profitability.

 

MARGINS: 
Supreme Industries' margin in Q2FY24 stood at 10.47%, a healthy improvement of 1.44% compared to the preceding quarter, Q1FY24. Year-on-year, the company's margin increased significantly by 6.55%, reflecting its ability to balance revenue and expenses effectively.

 

In conclusion, Supreme Industries' financial performance in Q2FY24 reflects robust growth in revenue, profitability, and margins. The company's agility in managing costs and its ability to adapt to changing market conditions have contributed to its impressive results. 

 

Stay tuned for more updates on Supreme Industries' financial performance in the coming quarters.

Top stories
Company

L&T Partners with PS Technology to Revolutionise Railways

6 mins read . 02 Aug 2024 . 12:45 PM

Company

Jindal Saw Q1 FY24 PAT Rises 67% to Rs 441 Cr

4 mins read . 02 Aug 2024 . 12:41 PM

Company

Pfizer Q1 FY25 PAT Zooms 61% to Rs 151 Cr

4 mins read . 02 Aug 2024 . 12:36 PM

Related Blogs
blog-logo

Share Market

blog-logo

9 mins read . 11 Oct 2024

Public Sector Undertakings in India

  • 0 people read
blog-logo

Share Market

blog-logo

7 mins read . 11 Oct 2024

How Did Rakesh Jhunjhunwala Become a Billionaire?

  • 0 people read
Kickstart your equities journey today You've got this
By submitting this I agree to the terms & conditions